Antibody and cytokines multiple ground glass opacity

Correlation between antibodies and cytokines in peripheral blood and multiple ground glass nodules in lung

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039223

Enrollment

Unknown

Registered

2020-10-22

Start date

2020-10-18

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple ground glass nodules in lung

Interventions

Multiple nodules groups:Nil

single nodule group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Between the ages of 18 and 70 years; 2. The subjects voluntarily participate in the study and have signed the informed consent; 3. Inpatient.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients with acute infection with clinical evidence; 3. Previous history of other systemic malignancies; 4. Acute and chronic allergic diseases; 5. Patients receiving immunosuppressive therapy; 6. Accompanied by autoimmune diseases and blood system diseases; 7. Serious cardiovascular and cerebrovascular diseases occurred within one month; 8. Liver and kidney dysfunction and other contraindications.

Design outcomes

Primary

Measure	Time frame
cytokines;antibody;	—

Countries

China

Contacts

Public ContactWei Liu

The First Bethune Hospital of Jilin University

wei-liuwei@hotmail.com+86 13596083366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026